TY - JOUR
T1 - Breath biomarkers in Non-Carcinogenic diseases
AU - Moura, Pedro Catalão
AU - Raposo, Maria
AU - Vassilenko, Valentina
N1 - Funding Information:
This work was financed by Fundação para a Ciência e Tecnologia (FCT – Portugal) through the grants UIDB/04559/2020(LIBPhys), and UIDP/04559/2020(LIBPhys) and PD/BDE/150627/2020.
Funding Information:
The authors would like to thank Fundação para a Ciência e Tecnologia (FCT - Portugal) for financing the grants UIDB/04559/2020(LIBPhys) and UIDP/04559/2020(LIBPhys). PCM would like to thank Fundação para a Ciência e Tecnologia (FCT - Portugal) for financing the grant PD/BDE/150627/2020 from the Doctoral NOVA I4H Program.
Publisher Copyright:
© 2023 The Author(s)
PY - 2024/1/1
Y1 - 2024/1/1
N2 - The analysis of volatile organic compounds (VOCs) from human matrices like breath, perspiration, and urine has received increasing attention from academic and medical researchers worldwide. These biological-borne VOCs molecules have characteristics that can be directly related to physiologic and pathophysiologic metabolic processes. In this work, gathers a total of 292 analytes that have been identified as potential biomarkers for the diagnosis of various non-carcinogenic diseases. Herein we review the advances in VOCs with a focus on breath biomarkers and their potential role as minimally invasive tools to improve diagnosis prognosis and therapeutic monitoring.
AB - The analysis of volatile organic compounds (VOCs) from human matrices like breath, perspiration, and urine has received increasing attention from academic and medical researchers worldwide. These biological-borne VOCs molecules have characteristics that can be directly related to physiologic and pathophysiologic metabolic processes. In this work, gathers a total of 292 analytes that have been identified as potential biomarkers for the diagnosis of various non-carcinogenic diseases. Herein we review the advances in VOCs with a focus on breath biomarkers and their potential role as minimally invasive tools to improve diagnosis prognosis and therapeutic monitoring.
KW - Biomarkers
KW - Breath Sampling
KW - Exhaled Breath
KW - Non-Carcinogenic Diseases
KW - VOCs
KW - Volatile Organic Compounds
UR - http://www.scopus.com/inward/record.url?scp=85179821153&partnerID=8YFLogxK
U2 - 10.1016/j.cca.2023.117692
DO - 10.1016/j.cca.2023.117692
M3 - Review article
C2 - 38065379
AN - SCOPUS:85179821153
SN - 0009-8981
VL - 552
JO - Clinica Chimica Acta
JF - Clinica Chimica Acta
M1 - 117692
ER -
